Skip to main content

Pityriasis Lichenoides Acuta

  • Chapter
  • First Online:
European Handbook of Dermatological Treatments
  • 15 Accesses

Abstract

Pityriasis lichenoides et varioliformis acuta (PLEVA) is an uncommon inflammatory skin disease. Generally, it is a self-healing process that resolves in a few months but, sometimes, may evolve into pityriasis lichenoides chronica. Cutaneous manifestation may vary from cases with mild presentation to forms with multiple ulcero-necrotic lesions associated to systemic symptoms. Generally, treatment is not necessary in the mild form. If the patient presents fever, an antibiotic treatment is recommended. Erythromycin is the antibiotic of choice in children, while tetracycline is preferable in adults. Cases with moderate cutaneous lesions, in the absence of fever, could be treated with topical corticosteroids and phototherapy. In adults, NB UVB or PUVA may be preferable. In more severe forms, usually associated to systemic symptoms, in addition to an oral antibiotic, it could be appropriate to prescribe a systemic steroid or methotrexate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 349.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 449.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aydogan K, Saricaoglu H, Turan H. Narrowband UVB (311 nm, TL01) phototherapy for pityriasis lichenoides. Photodermatol Photoimmunol Photomed. 2008;24:128–33.

    Article  PubMed  Google Scholar 

  • Bellinato F, Maurelli M, Gisondi P, Girolomoni G. A systematic review of treatments for Pityriasis Lichenoides. J Eur Acad Dermatol Venereol. 2019;33:2039–49.

    Article  CAS  PubMed  Google Scholar 

  • Boralevi F, Cotto E, Baysse L, et al. Is varicella-zoster virus involved in the etiopathogeny of pityriasis lichenoides? J Invest Dermatol. 2003;121:647–8.

    Article  PubMed  Google Scholar 

  • Borra T, Custrin A, Saggini A, et al. Pityriasis lichenoides, atypical pityriasis lichenoides, and related conditions: a study of 66 cases. Am J Surg Pathol. 2018;42:1101–12.

    Article  PubMed  Google Scholar 

  • Calzavara Pinton PC, Capezzera R, Zane C, et al. Medium-dose ultraviolet al therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. J Am Acad Dermatol. 2002;47:410–4.

    Article  Google Scholar 

  • Cornelison RL, Knox JM, Everett MA. Methotrexate for the treatment of Mucha-Habermann disease. Arch Dermatol. 1972;106:507–8.

    Article  PubMed  Google Scholar 

  • Ersoy-Evans S, Greco MF, Mancini AJ, Subaşi N, Paller AS. Pityriasis lichenoides in childhood: a retrospective review of 124 patients. J Am Acad Dermatol. 2007;56:205–10.

    Article  PubMed  Google Scholar 

  • Gelmetti C, Rigoni C, Alessi E, et al. Pityriasis lichenoides in children: a long-term follow-up of eighty-nine cases. J Am Acad Dermatol. 1990;23:473–8.

    Article  CAS  PubMed  Google Scholar 

  • Gritiyarangsan P, Pruenglampoo S, Ruangratanarote P. Comparative studies of treatments for pityriasis lichenoides. J Dermatol. 1987;14:258–61.

    Article  CAS  PubMed  Google Scholar 

  • Hapa A, Ersoy-Evans S, Karaduman A. Childhood pityriasis lichenoides and oral erythromycin. Pediatr Dermatol. 2012;29:719–24.

    Article  PubMed  Google Scholar 

  • Lis-Swiezty A, Michalska-Bankowska A, Zielonka-Kucharzewska A, et al. Successful therapy of cyclosporin A in pityriasis lichenoides et varioliformis acuta preceded by hand, foot and mouth disease. Antivir Ther. 2016;21:273–5.

    Article  Google Scholar 

  • Ogrum A, Takci Z, Seckin HY, et al. A case of pityriasis lichenoides: rapid resolution with azithromycin monotherapy in 3 weeks. Dermatol Ther. 2018;31:e12681.

    Article  PubMed  Google Scholar 

  • Pavlotsky F, Baum S, Barzilai A, et al. UVB therapy of pityriasis lichenoides – our experience with 29 patients. J Eur Acad Dermatol Venereol. 2006;20:542–7.

    Article  CAS  PubMed  Google Scholar 

  • Piamphongsant T. Tetracycline for the treatment of pityriasis lichenoides. Br J Dermatol. 1974;91:319–22.

    Article  CAS  PubMed  Google Scholar 

  • Powell FC, Muller SA. Psoralens and ultraviolet A therapy of pityriasis lichenoides. J Am Acad Dermatol. 1984;10:59–64.

    Article  CAS  PubMed  Google Scholar 

  • Sauer GC. Pentoxifylline (Trental) therapy for vasculitis of pityriasis lichenoides et varioliformis. Arch Dermatol. 1985;121:1487.

    Article  CAS  PubMed  Google Scholar 

  • Tay YK, Morelli JG, Weston WL. Experience with UVB phototherapy in children. Pediatr Dermatol. 1996;13:406–9.

    Article  CAS  PubMed  Google Scholar 

  • Truhan AP, Hebert AA, Esterly NB. Pityriasis lichenoides in children: therapeutic response to erythromycin. J Am Acad Dermatol. 1986;15:66–70.

    Article  CAS  PubMed  Google Scholar 

  • Zlatkov NB, Andreev VC. Toxoplasmosis and pityriasis lichenoides. Br J Dermatol. 1972;87:114–6.

    Article  CAS  PubMed  Google Scholar 

Further Reading

  • Bowers S, Warshaw EM. Pityriasis lichenoides and its subtypes. J Am Acad Dermatol. 2006;55:557–72.

    Article  PubMed  Google Scholar 

  • Farnaghi F, Seirafi H, Ehsani AH, Agdari ME, Noormohammadpour P. Comparison of the therapeutic effects of narrow band UVB vs. PUVA in patients with pityriasis lichenoides. J Eur Acad Dermatol Venereol. 2011;25:913–6.

    Article  CAS  PubMed  Google Scholar 

  • Fernandes NF, Rozdeba PJ, Schwartz RA, Kihiczak G, Lambert WC. Pityriasis lichenoides et varioliformis: a disease spectrum. Int J Dermatol. 2010;49:257–61.

    Article  PubMed  Google Scholar 

  • Geller L, Antonov NK, Lauren CT, Morel KD, Garzon MC. Pityriasis lichenoides in childhood: review of clinical presentation and treatment options. Pediatr Dermatol. 2015;32:579–92.

    Article  PubMed  Google Scholar 

  • Horie C, Mizukawa Y, Yamazaki Y, Shiohara T. Varicella zoster virus as a possible trigger for the development of pityriasis lichenoides et varioliformis acuta: retrospective analysis of our institutional cases. Clin Exp Dermatol. 2018;43:703–7.

    Article  CAS  PubMed  Google Scholar 

  • Ito N, Ohshima A, Hashizume H, Takigawa M, Tokura Y. Febrile ulceronecrotic Mucha-Habermann’s disease managed with methylprednisolone semipulse and subsequent methotrexate therapies. J Am Acad Dermatol. 2003;49:1142–8.

    Article  PubMed  Google Scholar 

  • Jung F, Sibbald C, Bohdanowicz M, Ingram JR, Piguet V. Systematic review of efficacies and adverse effects of treatments for pityriasis lichenoides. Br J Dermatol. 2020;183(6):1026–32. https://doi.org/10.1111/bjd.18977.

    Article  CAS  PubMed  Google Scholar 

  • Karouni M, Abou Rahal J, Kurban M, Kibbi AG, Abbas O. Possible role of plasmacytoid dendritic cells in pityriasis lichenoides. Clin Exp Dermatol. 2018;43:404–9.

    Article  CAS  PubMed  Google Scholar 

  • Kaufman WS, McNamara EK, Curtis AR, et al. Febrile ulceronecrotic Mucha-Habermann disease (pityriasis lichenoides et varioliformis acuta fulminans) presenting as Stevens-Johnson syndrome. Pediatr Dermatol. 2012;29:135–40.

    Article  PubMed  Google Scholar 

  • Khachemoune A, Blyumin ML. Pityriasis lichenoides: pathophysiology, classification, and treatment. Am J Clin Dermatol. 2007;8:29–36.

    Article  PubMed  Google Scholar 

  • Kempf W, Pfaltz K, Vermeer MH, et al. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Blood. 2011;118:4024–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kempf W, Kazakov DV, Palmedo G, et al. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases. Am J Surg Pathol. 2012;36:1021–9.

    Article  PubMed  Google Scholar 

  • Kim HS, Yu DS, Kim JW. A case of febrile ulceronecrotic Mucha-Habermann’s disease successfully treated with oral cyclosporin. J Eur Acad Dermatol Venereol. 2007;21:272–3.

    CAS  PubMed  Google Scholar 

  • Macias VC, Marques-Pinto G, Cardoso J. Phototherapy for pityriasis lichenoides: our experience. Cutan Ocul Toxicol. 2013;32:124–7.

    Article  PubMed  Google Scholar 

  • Marenco F, Fava P, Fierro MT, Quaglino P, Bernengo MG. High-dose immunoglobulins and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease. Dermatol Ther. 2010;23:419–22.

    Article  PubMed  Google Scholar 

  • Menzinger S, Frassati-Biaggi A, Leclerc-Mercier S, Bodemer C, Molina TJ, Fraitag S. Pityriasis lichenoides: a large histopathological case series with a focus on adnexotropism. Am J Dermatopathol. 2020;42:1–10.

    Article  PubMed  Google Scholar 

  • Miyamoto T, Takayama N, Kitada S, Hagari Y, Mihara M. Febrile ulceronecrotic Mucha-Habermann disease: a case report and a review of the literature. J Clin Pathol. 2003;56:795–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Romani J, Puig L, Fernandez-Figueras MT, de Moragas JM. Pityriasis lichenoides in children: clinicopathologic review of 22 patients. Pediatr Dermatol. 1998;15:1–6.

    Article  CAS  PubMed  Google Scholar 

  • Zaaroura H, Sahar D, Bick T, Bergman R. Relationship between pityriasis lichenoides and mycosis fungoides: a clinicopathological, immunohistochemical, and molecular study. Am J Dermatopathol. 2018;40:409–15.

    Article  PubMed  Google Scholar 

  • Zang JB, Coates SJ, Huang J, Vonderheid EC, Cohen BA. Pityriasis lichenoides: long-term follow-up study. Pediatr Dermatol. 2018;35:213–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luca Fania .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fania, L., Didona, B. (2023). Pityriasis Lichenoides Acuta. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D'Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Cham. https://doi.org/10.1007/978-3-031-15130-9_71

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-15130-9_71

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-15129-3

  • Online ISBN: 978-3-031-15130-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics